|Inflammatory Bowel Diseases||Therapeutic Drug Monitoring||Colon Cancer Prevention|
R-Biopharms Gastroenterology product portfolio is dedicated to the advanced diagnosis of gut-related diseases. The ELISA tests are suited for single plate or medium-high-throughput analysis on automated readers.
Inflammatory Bowel Disease
Therapeutic Drug Monitoring of Infliximab (Remicade®) and Adalimumab (Humira®)
- RIDASCREEN® IFX Monitoring
- RIDASCREEN® Anti-IFX Antibodies
- RIDASCREEN® ADM Monitoring
- RIDASCREEN® Anti-ADM Antibodies NEW!
- RIDA®QUICK IFX Monitoring NEW!
Colon Cancer Prevention
- Pankreatic Elastase ELISA (4 standard version)
- Pankreatic Elastase ELISA SK15 (5 standard version)
- Pankrin® ELISA
Markers and their diagnostic relevance at a glance:
Indicator of gastrointestinal inflammation which is used for differentiation of IBD and IBS and for treatment monitoring
Therapeutic drug monitoring of IFX (Remicade®) supports the optimization of treatment and reduction of treatment costs
Haemoglobin and Haemo-/Haptoglobin Complex
Markers for colon cancer screening. A combined testing of both parameters increases the probability to detect ademonas
α1-Antitrypsin and sIgA
Indicators for the integrity of the gut wall, relevant for monitoring and diagnosing the Leaky Gut Syndrome
Pancreatic Elastase and Prankrin ELISA
Markers for the detection pancreatic insufficiency and pancreatitis
Stool collection tubes
Easy, rapid and clean sampling of the matrix stool.